Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...
The respiratory syncytial virus (RSV) space may have filled up over the past year, but that isn’t deterring Vicebio or its ...
The first RSV vaccines were approved in the US in May last year. GSK’s Arexvy vaccine generated more than $1bn in sales in ...